All In Biotech

Drug Trial Radar · NCT06366750

A Study of Barzolvolimab in Patients With Prurigo Nodularis

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Patients With Prurigo Nodularis

Last checked: Nov 20, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 140 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

140

Actual

Start

Apr 12, 2024

Primary completion

Mar 17, 2026

Study completion Mar 2027

Sponsor

Lead sponsor
Celldex TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.

Conditions

  • Prurigo Nodularis

Interventions

  • barzolvolimabBiological

    subcutaneous administration

  • Matching PlaceboOther

    subcutaneous administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with improvement in Worst Itch Numeric Rating Scale (WI-NRS) by ≥ 4 from baseline to Week 12.Time frame: From Day 1 (first dose) to Day 85 (week 12)

Locations

72 sites in 6 countries. Site status is shown where the registry gives one.

  • Total Dermatology

    Birmingham, Alabama

  • Cahaba Dermatology Skin Health Center

    Birmingham, Alabama

  • Investigate MD, LLC

    Scottsdale, Arizona

  • Scottsdale Clinical Trials

    Scottsdale, Arizona

  • Center for Dermatology Clinical Research, Inc

    Fremont, California

  • Profound Research LLC

    Oceanside, California

  • Empire Clinical Research

    Pomona, California

  • University of California San Francisco

    San Francisco, California

  • University of California, San Francisco

    San Francisco, California

  • Dermatology Institute & Skin Care Center

    Santa Monica, California

  • Focus Clinical Research

    West Hills, California

  • Encore Medical Research Boynton Beach

    Boynton Beach, Florida

  • Biobrilliance Medical Research Center

    Hialeah, Florida

  • Encore Medical Research

    Hollywood, Florida

  • Life Arc Research Centers Corp

    Miami, Florida

  • University of Miami

    Miami, Florida

  • Advanced Clinical Research Institute

    Tampa, Florida

  • Encore Medical Research of Weston

    Weston, Florida

  • Emory University

    Atlanta, Georgia

  • Centricity Research

    Columbus, Georgia

  • Treasure Valley Medical Research

    Boise, Idaho

  • MetroMed Clinical Trials

    Chicago, Illinois

  • DS Research of Southern Indiana, LLC

    Clarksville, Indiana

  • Equity Medical

    Bowling Green, Kentucky

  • DS Research of Kentucky, LLC

    Louisville, Kentucky

  • Revival Research Institute, LLC

    Troy, Michigan

  • Medisearch, LLC

    Saint Joseph, Missouri

  • Skin Specialists PC

    Omaha, Nebraska

  • University of New Mexico Department of Dermatology

    Albuquerque, New Mexico

  • Equity Medical

    New York, New York

  • Apex Clinical Research Center - Canton

    Canton, Ohio

  • UC Health Physicians Office Dermatology

    Cincinnati, Ohio

  • Paddington Testing, PO

    Philadelphia, Pennsylvania

  • Columbia Dermatology and Aesthetics

    Columbia, South Carolina

  • International Clinical Research - Tennessee LLC

    Murfreesboro, Tennessee

  • Dermatology Treatment and Research Center

    Dallas, Texas

  • Center for Clinical Studies

    Webster, Texas

  • Stratica Dermatology

    Edmonton, Alberta, Canada

  • SimcoDerm Medical and Surgical Dermatology Center

    Barrie, Ontario, Canada

  • Kingsway Clinical Research

    Etobicoke, Ontario, Canada

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.